EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF)

Christine Hachem, William Tressel, Karen D Hinckley Stukovsky, Cienn N Joyeux, Sarah Jane Schwarzenberg, Steven D Freedman, NICE-CF Consortium

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2026.05.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Christine Hachem und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Saint Louis University, 1225 South Grand, Saint Louis, MO 61304, United States. Electronic address: Christine.hachem…. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, Cystic Fibrosis, Early Detection of Cancer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cystic Fibrosis Foundation, Cook Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: People with Cystic Fibrosis (PwCF) have a higher risk of digestive cancers compared to non-CF age-matched cohorts. Colonoscopy is the standard for colorectal cancer (CRC) and precancerous lesion screening. In the general population stool-based testing provides a non-invasive option for CRC screening. We evaluated performance and feasibility of stool-based testing for CRC screening in PwCF. METHODS: This was a cross-sectional multi-center study comparing stool-based testing (multi-target DNA-based test/Cologuard™ (mt-sDNA) and quantitative FIT test) to colonoscopy for CRC screening in PwCF. NPV and sensitivity of stool-based testing to detect non-advanced precancerous polyps and advanced neoplasia (CRC or advanced precancerous lesions) in PwCF were calculated. RESULTS: 362 participants enrolled at 26 US centers. 254 with analyzable mt-sDNA and/or FIT test completed colonoscopy (70% of enrolled). Mean age was 47 years; 50% were female. The majority were Caucasian; 78% reported CFTR modulator use. Prevalence of non-advanced precancerous polyps and advanced neoplasia was 46%. Participants age ≥ 40 had similar rates to < 40 (46% vs. 42%), as did males and females (48% vs. 43%). FIT in PwCF for non-advanced precancerous polyps and advanced neoplasia had NPV of 0.55 (0.48-0.61), PPV of 0.61 (0.39-0.80), and low sensitivity of 0.11. FIT for advanced neoplasia alone had improved NPV but low sensitivity and PPV. Mt-sDNA in PwCF with non-advanced precancerous polyps and advanced neoplasia had NPV of 0.58 (0.51, 0.64), PPV of 0.59 (0.45- 0.72), and low sensitivity of 0.27. Mt-sDNA for advanced neoplasia alone also demonstrated improved NPV but low PPV and low sensitivity. CONCLUSION: FIT and mt-sDNA testing demonstrate low NPV and sensitivity in the high-risk CF population; these tests cannot be recommended as alternatives to colonoscopy for CRC screening for PwCF. CLINICALTRIALS: gov number: NCT05362344.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColonoscopyColorectal NeoplasmsCystic FibrosisEarly Detection of CancerAdultFemaleHumansMaleMiddle AgedCross-Sectional StudiesFecesMass ScreeningPrecancerous ConditionsSensitivity and SpecificityUnited States

Stichwörter der Autor:innen

Colon cancerCystic fibrosisStool-based testing

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, Saint Louis University, 1225 South Grand, Saint Louis, MO 61304, United States. Electronic address: Christine.hachem@imail.org.
  • Collaborative Health Studies Coordinating Center, Department of Biostatistics, School of Public Health, University of Washington, 6200 NE 74th Street, Bldg 29, Ste 310, Seattle, WA 98115, United States.
  • Collaborative Health Studies Coordinating Center, Department of Biostatistics, School of Public Health, University of Washington, 6200 NE 74th Street, Bldg 29, Ste 310, Seattle, WA 98115, United States. Electronic addre…
  • Pediatric Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Academic Office Building, 2450 Riverside Ave S AO-201, Minneapolis, MN 55454, United States. Electronic address: Schwa005@umn.edu.
  • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Dana 501, 330 Brookline Ave, Boston, MA 02215, United States. Electronic address: sfreedma@bidmc.harvard.edu.

Förderung

  • Cystic Fibrosis Foundation
  • Cook Family Foundation

Zitieren

APA

Hachem, C., Tressel, W., Hinckley Stukovsky, K. D., Joyeux, C. N., Schwarzenberg, S. J., Freedman, S. D., & NICE-CF Consortium (2026). A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF). Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.05.017

Vancouver

Hachem C, Tressel W, Hinckley Stukovsky KD, Joyeux CN, Schwarzenberg SJ, Freedman SD, et al. A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF). Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.05.017

BibTeX
@article{Hachem2026,
  author = {Hachem, Christine and Tressel, William and Hinckley Stukovsky, Karen D and Joyeux, Cienn N and Schwarzenberg, Sarah Jane and Freedman, Steven D and NICE-CF Consortium, NICE-CF Consortium},
  title = {A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF)},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.05.017}
}
Kostenlos starten →